These 10 medtech companies care a lot about research

November 29, 2017 By Chris Newmarker

9. BioMerieux

The BioMérieux Vitek MS [Image courtesy of BioMérieux]

R&D spend: $301.0 million

Percent of revenues: 12.9%

2017 overall revenue rank: 36

BioMérieux (Marcy l’Étoile, France) provides in vitro diagnostics products including reagents, instruments and software. In July, the company announced U.S. FDA 510(k) clearance for its Vitek MS – its MALDI-TOF1 mass spectrometry system – for the expanded identification of mycobacteria, Nocardia and molds. The clearance came after BioMérieux submitted data from a multi-center study consisting of 2,695 clinical isolates for 47 molds, 19 mycobacteria, and 12 Nocardia.

Next>>

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.